Cargando…

Natural Products/Bioactive Compounds as a Source of Anticancer Drugs

SIMPLE SUMMARY: Cancer is considered as a large group of diseases involving abnormal cell growth, which results in an alarming rise in the mortality rate at the worldwide level. Presently, the main point of interest in pharmaceutical research is the development of the novel and efficient anticancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Asma, Syeda Tasmia, Acaroz, Ulas, Imre, Kálmán, Morar, Adriana, Shah, Syed Rizwan Ali, Hussain, Syed Zajif, Arslan-Acaroz, Damla, Demirbas, Hayri, Hajrulai-Musliu, Zehra, Istanbullugil, Fatih Ramazan, Soleimanzadeh, Ali, Morozov, Dmitry, Zhu, Kui, Herman, Viorel, Ayad, Abdelhanine, Athanassiou, Christos, Ince, Sinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777303/
https://www.ncbi.nlm.nih.gov/pubmed/36551687
http://dx.doi.org/10.3390/cancers14246203
_version_ 1784856070247677952
author Asma, Syeda Tasmia
Acaroz, Ulas
Imre, Kálmán
Morar, Adriana
Shah, Syed Rizwan Ali
Hussain, Syed Zajif
Arslan-Acaroz, Damla
Demirbas, Hayri
Hajrulai-Musliu, Zehra
Istanbullugil, Fatih Ramazan
Soleimanzadeh, Ali
Morozov, Dmitry
Zhu, Kui
Herman, Viorel
Ayad, Abdelhanine
Athanassiou, Christos
Ince, Sinan
author_facet Asma, Syeda Tasmia
Acaroz, Ulas
Imre, Kálmán
Morar, Adriana
Shah, Syed Rizwan Ali
Hussain, Syed Zajif
Arslan-Acaroz, Damla
Demirbas, Hayri
Hajrulai-Musliu, Zehra
Istanbullugil, Fatih Ramazan
Soleimanzadeh, Ali
Morozov, Dmitry
Zhu, Kui
Herman, Viorel
Ayad, Abdelhanine
Athanassiou, Christos
Ince, Sinan
author_sort Asma, Syeda Tasmia
collection PubMed
description SIMPLE SUMMARY: Cancer is considered as a large group of diseases involving abnormal cell growth, which results in an alarming rise in the mortality rate at the worldwide level. Presently, the main point of interest in pharmaceutical research is the development of the novel and efficient anticancer drugs based on natural sources. In this regard, plants, and some microbial species, due to their composition, ecology, phytochemical, and ethnopharmacological properties, play a significant role. Accordingly, a series of plant-derived bioactive compounds are in the clinical development phase against cancer. The present review highlights the significance of several medicinal plants, plant extracts, and their bioactive compounds for their potential anticancer activities. The presented results can be useful for researchers in developing novel anticancer drugs, public health specialists, and for the public in general. ABSTRACT: Cancer is one of the major deadly diseases globally. The alarming rise in the mortality rate due to this disease attracks attention towards discovering potent anticancer agents to overcome its mortality rate. The discovery of novel and effective anticancer agents from natural sources has been the main point of interest in pharmaceutical research because of attractive natural therapeutic agents with an immense chemical diversity in species of animals, plants, and microorganisms. More than 60% of contemporary anticancer drugs, in one form or another, have originated from natural sources. Plants and microbial species are chosen based on their composition, ecology, phytochemical, and ethnopharmacological properties. Plants and their derivatives have played a significant role in producing effective anticancer agents. Some plant derivatives include vincristine, vinblastine, irinotecan, topotecan, etoposide, podophyllotoxin, and paclitaxel. Based on their particular activity, a number of other plant-derived bioactive compounds are in the clinical development phase against cancer, such as gimatecan, elomotecan, etc. Additionally, the conjugation of natural compounds with anti-cancerous drugs, or some polymeric carriers particularly targeted to epitopes on the site of interest to tumors, can generate effective targeted treatment therapies. Cognizance from such pharmaceutical research studies would yield alternative drug development strategies through natural sources which could be economical, more reliable, and safe to use.
format Online
Article
Text
id pubmed-9777303
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97773032022-12-23 Natural Products/Bioactive Compounds as a Source of Anticancer Drugs Asma, Syeda Tasmia Acaroz, Ulas Imre, Kálmán Morar, Adriana Shah, Syed Rizwan Ali Hussain, Syed Zajif Arslan-Acaroz, Damla Demirbas, Hayri Hajrulai-Musliu, Zehra Istanbullugil, Fatih Ramazan Soleimanzadeh, Ali Morozov, Dmitry Zhu, Kui Herman, Viorel Ayad, Abdelhanine Athanassiou, Christos Ince, Sinan Cancers (Basel) Review SIMPLE SUMMARY: Cancer is considered as a large group of diseases involving abnormal cell growth, which results in an alarming rise in the mortality rate at the worldwide level. Presently, the main point of interest in pharmaceutical research is the development of the novel and efficient anticancer drugs based on natural sources. In this regard, plants, and some microbial species, due to their composition, ecology, phytochemical, and ethnopharmacological properties, play a significant role. Accordingly, a series of plant-derived bioactive compounds are in the clinical development phase against cancer. The present review highlights the significance of several medicinal plants, plant extracts, and their bioactive compounds for their potential anticancer activities. The presented results can be useful for researchers in developing novel anticancer drugs, public health specialists, and for the public in general. ABSTRACT: Cancer is one of the major deadly diseases globally. The alarming rise in the mortality rate due to this disease attracks attention towards discovering potent anticancer agents to overcome its mortality rate. The discovery of novel and effective anticancer agents from natural sources has been the main point of interest in pharmaceutical research because of attractive natural therapeutic agents with an immense chemical diversity in species of animals, plants, and microorganisms. More than 60% of contemporary anticancer drugs, in one form or another, have originated from natural sources. Plants and microbial species are chosen based on their composition, ecology, phytochemical, and ethnopharmacological properties. Plants and their derivatives have played a significant role in producing effective anticancer agents. Some plant derivatives include vincristine, vinblastine, irinotecan, topotecan, etoposide, podophyllotoxin, and paclitaxel. Based on their particular activity, a number of other plant-derived bioactive compounds are in the clinical development phase against cancer, such as gimatecan, elomotecan, etc. Additionally, the conjugation of natural compounds with anti-cancerous drugs, or some polymeric carriers particularly targeted to epitopes on the site of interest to tumors, can generate effective targeted treatment therapies. Cognizance from such pharmaceutical research studies would yield alternative drug development strategies through natural sources which could be economical, more reliable, and safe to use. MDPI 2022-12-15 /pmc/articles/PMC9777303/ /pubmed/36551687 http://dx.doi.org/10.3390/cancers14246203 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Asma, Syeda Tasmia
Acaroz, Ulas
Imre, Kálmán
Morar, Adriana
Shah, Syed Rizwan Ali
Hussain, Syed Zajif
Arslan-Acaroz, Damla
Demirbas, Hayri
Hajrulai-Musliu, Zehra
Istanbullugil, Fatih Ramazan
Soleimanzadeh, Ali
Morozov, Dmitry
Zhu, Kui
Herman, Viorel
Ayad, Abdelhanine
Athanassiou, Christos
Ince, Sinan
Natural Products/Bioactive Compounds as a Source of Anticancer Drugs
title Natural Products/Bioactive Compounds as a Source of Anticancer Drugs
title_full Natural Products/Bioactive Compounds as a Source of Anticancer Drugs
title_fullStr Natural Products/Bioactive Compounds as a Source of Anticancer Drugs
title_full_unstemmed Natural Products/Bioactive Compounds as a Source of Anticancer Drugs
title_short Natural Products/Bioactive Compounds as a Source of Anticancer Drugs
title_sort natural products/bioactive compounds as a source of anticancer drugs
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777303/
https://www.ncbi.nlm.nih.gov/pubmed/36551687
http://dx.doi.org/10.3390/cancers14246203
work_keys_str_mv AT asmasyedatasmia naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT acarozulas naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT imrekalman naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT moraradriana naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT shahsyedrizwanali naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT hussainsyedzajif naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT arslanacarozdamla naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT demirbashayri naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT hajrulaimusliuzehra naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT istanbullugilfatihramazan naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT soleimanzadehali naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT morozovdmitry naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT zhukui naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT hermanviorel naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT ayadabdelhanine naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT athanassiouchristos naturalproductsbioactivecompoundsasasourceofanticancerdrugs
AT incesinan naturalproductsbioactivecompoundsasasourceofanticancerdrugs